Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS® (sotorasib)…

MIAMI, Jan. 17, 2025 /PRNewswire/ — Adjust, a vaping explorer, today in the US introduces myFlavor, a single-use vape offering a customizable dual-flavor experience. myFlavor sets itself apart by mixing two flavors in different ratios, catering to diverse palates. Personalized Flavor…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.